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Abstract
Molecular mechanisms involved in epileptogenesis in the developing brain remain poorly understood. The gene array
approach could reveal some of the factors involved by allowing the identification of a broad scale of genes altered by
seizures. In this study we used microarray analysis to reveal the gene expression profile of the laser microdissected
hippocampal CA1 subregion one week after kainic acid (KA)-induced status epilepticus (SE) in 21-day-old rats, which are
developmentally roughly comparable to juvenile children. The gene expression analysis with the Chipster software
generated a total of 1592 differently expressed genes in the CA1 subregion of KA-treated rats compared to control rats. The
KEGG database revealed that the identified genes were involved in pathways such as oxidative phosporylation (26 genes
changed), and long-term potentiation (LTP; 18 genes changed). Also genes involved in Ca
2+ homeostasis, gliosis,
inflammation, and GABAergic transmission were altered. To validate the microarray results we further examined the protein
expression for a subset of selected genes, glial fibrillary protein (GFAP), apolipoprotein E (apo E), cannabinoid type 1
receptor (CB1), Purkinje cell protein 4 (PEP-19), and interleukin 8 receptor (CXCR1), with immunohistochemistry, which
confirmed the transcriptome results. Our results showed that SE resulted in no obvious CA1 neuronal loss, and alterations in
the expression pattern of several genes during the early epileptogenic phase were comparable to previous gene expression
studies of the adult hippocampus of both experimental epileptic animals and patients with temporal lobe epilepsy (TLE).
However, some changes seem to occur after SE specifically in the juvenile rat hippocampus. Insight of the SE-induced
alterations in gene expression and their related pathways could give us hints for the development of new target-specific
antiepileptic drugs that interfere with the progression of the disease in the juvenile age group.
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Introduction
Epilepsy, one of the most common neurological disorders
affecting up to 1% of the population, is caused by a number of
both unknown and known factors such as trauma, hypoxia,
postnatal insults, and status epilepticus (SE) [1,2]. In experimental
animal models, SE can be induced by different chemoconvulsants,
e.g. kainic acid (KA), which induces region-specific neuropatho-
logical changes in the hippocampus comparable to those of
patients with chronic temporal lobe epilepsy (TLE) [3,4,5]. In
addition to region-specificity, earlier studies indicate that the
extent and localization of KA-induced hippocampal damage is
age-specific, the immature rats (,21-day old) having minor or
even no obvious damage [6,7,8], while degeneration of CA1 and
CA3 pyramidal neurons and hilar interneurons have frequently
been documented in adult rats [3,6,9].
The acute seizure-induced excitotoxic insult is known to initiate a
process of changes defined as epileptogenesis, which finally leads to
spontaneous seizures, i.e. epilepsy in the majority of adult rats
[1,10,11]. In immature rats, the appearance of spontaneous seizures
and other long-term consequences seems to be less severe [6,10,12].
In spite of numerous studies focusing on epileptogensis both in adult
and immature brain, its cellular and molecular mechanisms have
remained largely undiscovered. In search for factors involved in
epileptogenesis in the hippocampus, the gene expression approach
using microarrays has recently been successfully applied. The results
of these studies suggest that the expression of a number of genes is
altered in the adult rat hippocampus after SE induced by KA [13,14],
pentylenetetrazol [15], and electrical stimulation [16,17]. The results
of more detailed gene microarray studies carried out in specimen
microdissected from the selected hippocampal sub-regions have
revealed that the alterations are not uniform, but region-specifically
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that the targeted gene array approach reveals more exactly the
region-specific pathways activated in the course of epileptogenesis.
Furthermore, as seizure-induced pathology seems to be age-specific,
there could also be age-specific differences in the pathways altered by
seizures, which could elucidate in more detail the postulated
differences in epileptogenesis between the immature and mature
brain. However, to our knowledge, there is only one earlier
microarray study focusing on gene expression in normal immature
rats (P3) [21], and no earlier studies after experimental SE either in
immature or juvenile animals.
In our current study, we specifically focused on juvenile, 21-day-
old (P21) rats, in which KA-induced SE leads to selective damage
of hippocampal CA1 pyramidal neurons while saving neurons of
the other sub-regions [7,23]. We searched for alterations in the
gene expression pattern during the early epileptogenetic phase, i.e.
one week after SE, and compared the results with those of age-
matched control rats. To detect specifically changes in the CA1
pyramidal neurons, we used the laser-capture microdissection
technique that allows the precise isolation of the region of interest.
The transcriptome was analyzed by using gene expression
microarrays which generated differentially expressed genes, and
the results of certain, selected genes of interest were confirmed at
the protein level using immunohistochemistry.
Materials and Methods
Kainate treatment of the rats
P21 Sprague–Dawley male rats were chosen for these
experiments (n=4, in both the control and KA-treated groups).
A single dose of KA (Tocris Cookson Ltd., Avomouth, UK)
(7 mg/kg) was injected intraperitoneally to the rats, which were
thereafter carefully followed up to detect signs of seizures, as
earlier described in detail [23]. Within 15 min after the injection,
rats first showed deep breathing and increased salivation followed
by scratching with further progression to rearing and generalized
tonic/clonic seizures within 50–60 min, which lasted for 2–3 h.
After a follow-up for further 2 h after the cessation of behavioral
seizures, rats were taken back to their cages, and sacrificed 7 days
after the KA injection. Control rats received the same volume of
0.9% NaCl as those of KA-treated, but were otherwise treated as
the KA-injected rats described above. About 80% of KA-treated
animals developed SE, and only animals which experienced SE
were included in this study. All animal procedures were conducted
in accordance with the guidelines of the European Community
Council Directives 86/609/EEC, and had the approval of the
Office of the Regional Government of Western Finland. Using our
protocol the mortality of rats was zero. All efforts were made to
minimize the pain, discomfort, and number of experimental
animals.
Tissue collection
After decapitation, brains where dissected into halves. One half
of the brain was rapidly frozen in liquid nitrogen for the
microarray study, and the other half was submerged in 4%
paraformadehyde (PFA) in phosphate-buffered saline (PBS,
pH 7.4) for immunocytochemistry and Fluoro-Jade B (FJB)
staining. For the transcriptome studies, the liquid nitrogen-frozen
brains were cut into 40 mm coronal slices onto PALM membrane
slides (PALM Microlaser Technologies GmbH, Germany), and
stored at 280uC. To visualize the various hippocampal
subregions, all slices prepared from the hippocampi of control
and KA-treated rats were stained with hematoxylin-eosin, and
the hippocampal pyramidal CA1 cell layer of the control and
KA-treated rats was cut using the laser capture micro-dissection
(LCM) technology, and catapulted on PALM adhesive caps (see
Fig. 1D). Eight consecutive sections obtained from each animal
were used to maximize the yield and quality of the extracted total
RNA and to circumvent the need of additional PCR-amplifica-
tion steps for the subsequent microarray labelling of the RNA-
samples.
RNA isolation and assessment of the RNA quality
The total RNA of the LCM samples was isolated using the
EPICENTRE Array Pure
TM Nano – scale RNA Purification Kit
(Madison, USA). The RNA solution was treated with the DNase
and RNase inhibitor (ScriptGuard
TM, included in the Array
Pure
TM Nano Kit), and the quality and approximate quantity of
the resulting RNA were determined spectrofotometrically using
Nanodrop-1000 (Thermo Fischer Scientific, Wilmington, USA),
and a capillary electrophoresis system (Experion, Bio-Rad).
Microarray analysis
Total RNA (100 ng), isolated from LCM-samples that were
dissected from each individual experimental animal separately as
described above, was amplified, labeled, and hybridized according
to the manufacturers’ protocols (Illumina, San Diego, CA, USA).
In brief, biotin-labeled cRNA was prepared by a linear
amplification method using the IlluminaH TotalPrep
TM RNA
Amplification Kit. After the first and second strand synthesis, the
cDNA served as the template for an in vitro transcription reaction
to produce the biotinylated, amplified target cRNA (750 ng) used
for the Illumina RatRef-12 Expression BeadChip arrays with each
sample hybridized on separate arrays. After hybridization and
washing the arrays were scanned and read by the Illumina Bead
Array Reader, and the data was extracted by using the Illumina
Bead Studio (version 3). All microarray data was deposited in
ArrayExpress with the accession number E-TABM-881, according
to the guidelines of MIAME by the European Bioinformatics
Institute (www.ebi.ac.uk/microrarray_as/).
Microarray data analysis
Microarray data analysis (Chipster software v1.1.0, CSC,
Finland) was applied to identify those genes that had statistically
significant differences in their expression between the groups. The
outliers were excluded based on their expression intensity within a
group, and those samples did not affect the outcome of the further
analysis. In order to distinguish the two groups under assessment,
phenodata was created, and the normalization of genes was made
by the quantile normalization method (which makes the
expression value to follow the same distribution on all chips),
with no production of flags on the RatRef-12 chip type,
beadstudio version 3, and by using ‘‘Probe ID’’ as identifier. In
order to discard unreliable and uninformative data points, the
filtering process was carried out, and the group of genes that have
a corrected p-value smaller than the cut-off p-value (0.05) passed
the statistical ‘‘two group test’’. The filtering was performed by
using the empirical Bayes method with Benjamin and Hochberg
post hoc test, and the contrasts were created by using the Limma R/
Bioconductor (www.bioconductor.org). Finally, the data was
clustered by using the non-hierarchical K-means clustering for
genes, which identifies k points that function as cluster centers.
Each data point was then assigned to one of these centers in a way
that minimizes the sum of the distances between all points and
their centers [24]. The pathway analysis was performed by ‘Gene
set test’, which analyzes the statistical significance of a set of genes
simultaneously ranked by p-value and generates the KEGG
categories (Chipster manual). The KEGG pathway maps and the
Seizures in Juvenile Rats
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Bioinformatics Resources from the National Institute of Allergy
and Infectious Diseases (NIAID), NIH (http://david.abcc.ncifcrf.
gov/).
Immunohistochemistry
Immunohistochemistry was carried out to verify the gene array
results of certain, selected genes of interest. For that, brains of the
KA-injected and their respective saline controls were used for the
immunohistochemical study, which was carried out as previously
described in detail [25]. After fixation in 4% PFA in PBS (pH 7.4),
brains were cryoprotected in 30% sucrose in PBS at +4uC, frozen,
and thereafter kept at 280uC until used. For the immunostaining,
brains were cryosectioned in 30 mm slices, collected in PBS
(pH 7.4), and processed in a free-floating system. Slices were first
incubated in the blocking solution (BS) containing 2% bovine
serum albumin, 2% goat serum, and 0.1% Triton X-100 in PBS
(pH 7.4) for 1 h at room temperature, and thereafter with the
primary antibodies for 24–48 h at +4uC in BS at the following
dilutions: glial fibrillary acid (GFAP; 1:3000, Sigma, St. Louis,
USA), apolipoprotein E (apo E; 1:1000, Abcam, Cambridge, UK),
cannabinoid type 1 receptor (CB1; 1:1000, Abcam), Purkinje cell
protein 4 (PEP-19; 1:500, Santa Cruz Biotechnology, Santa Cruz,
CA, USA), and interleukin 8 receptor (CXCR1; 1:1000, Abcam).
After washing in PBS, slices were incubated with the biotin-
conjugated secondary antibody (1:4000) in BS, rinsed with PBS,
and incubated with the avidin-peroxidase conjugate (Vectastain
ABC Kit, Vector Laboratories, Burlingame, CA, USA) in BS for
1 h at room temperature. The staining was detected using 3,3-
diaminobenzidinetetrahydrochloride (Sigma) as a chromogen, and
further processed as earlier described [25]. Alternatively, Alexa
568 (1:2000, Invitrogen) was used as a secondary antibody. In each
experiment, KA-treated and control brains of the same age were
processed simultaneously, and two to three slices from each brain,
in which the primary antibody was omitted but which were
otherwise treated as indicated above, served as negative control.
Preparations were examined with a Leica DM R microscope
(Heerbrugg, Switzerland) under the bright field or fluorescence
optics.
Fluoro-Jade B staining
FJB, an anionic fluorescein with excitation peaks at 362 and
390 nm and the emission peak at 550 nm, is a marker of neuronal
degeneration regardless of the nature of the injury [26]. FJB
staining was carried out in brain slices prepared from 4% PFA-
fixed brains 7 days after the KA injection. Brain slices (20 mm
thick) were cut and mounted on gelatin-coated glasses. The FJB
staining was carried out as previously described in detail [8] with
minor modifications. Briefly, brain slices were rehydrated with
alcohol series, transferred for 2–5 min to 0.06% potassium
permanganate (KMnO4), washed with distilled water, and
transferred to 0.001% FJB solution for 30 min. After that, slides
were washed, dried, cleared in xylene, coverslipped with mounting
medium, and examined with the Leica DM R microscope under
fluorescence filters.
Hematoxylin-Eosin staining
The hematoxylin-eosin staining was performed using basic
histological staining protocols. Briefly, brain slices (40 mm slices on
PALM membrane slides) were stained with Mayer’s Hematoxylin,
dehydrated in ethanol series, and cleared in xylene before using
the LCM.
Figure 1. Neuronal CA1 pyramidal cell damage and the region-specific laser microdisecction one week after SE. Fluoro-Jade B staining
of a representative control (A) and KA-treated rat (B) one week after SE. Fig.1B shows positively stained CA1 pyramidal neurons (see also the inset in
B). Figs.1C and D show hematoxylin-eosin staining of the CA1 pyramidal layer of a KA-treated rat before and after laser microdissection, respectively.
Scale bars: A and B: 200 mm; C and D: 75 mm. Abbreviations: CA1 pyr, stratum pyramidale of CA1; DG, dentate gyrus; KA, kainic acid.
doi:10.1371/journal.pone.0010733.g001
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Selective neuronal damage after SE in the CA1 region
The extent of regional hippocampal neuronal damage after KA-
induced SE was assessed using FJB staining. Fig. 1A shows a
representative image of the hippocampus of a P21 saline-injected
control rat, in which no positively FJB-stained neurons were detected.
In contrast, numerous FJB-stained pyramidal neurons appeared
exclusively in the CA1 region one week after KA-induced SE
(Fig. 1B). The hematoxylin-eosin staining (Fig. 1C) accurately
indicated the CA1 pyramidal cell layer, which did not show any
obvious neuronal loss. This region was microdissected with laser
(Fig. 1D), and further processed to extract the total RNA.
Microarray data analysis profile
Transcriptional responses of the CA1 region with the
subsequent Illumina microarray analysis returned a total of 1592
genes that were statistically differentially expressed in KA-treated
as compared to the age-matched control animals with the filter
cut-off set at the 2-fold difference in the gene expression level with
the p-value ,0.05. The contrasts in the gene expression levels that
were revealed by the data analysis between the KA-treated and
control animals were visualized by a heatmap (Fig. 2), in which the
yellow colour indicated up-regulation, and the blue colour down-
regulation in the contrasted samples. The heatmap of the samples
showed that the contrasting algorithm divided the samples in two
distinct groups with the replicates of the control samples in one
group (n=4), and the samples from KA-treated rats in the other
group (n=4) (Fig. 2). The low variation between the samples from
KA-treated rats may be due to the fact that all the treated animals
included in this study experienced SE, and showed concomitant
neurodegeneration in the CA1 pyramidal cell layer. This may
have contributed to the high correlations between the biological
samples within the groups (Fig. 2), that in turn resulted in a
relatively high number of genes with a statistically significant
difference in their expression. Further data mining of the
transcriptome analysis included K-nearest neighbour classification.
Using the K-means method the genes were classified in 10
different clusters representing the functionally distinct gene
expression patterns that visualize the full extraction of the
biologically significant phenomena in the data (Fig. 3).
Genes related to pathways
The subsequent KEGG-test for the probe set over-representation
analysis revealed the 15 significantly (p,0.05) changed KEGG-
pathways in response to KA-treatment (see Materials and Methods
andTable1).Someofthemostpronouncedlyaffectedpathwayswere
involved in oxidative phosphorylation (26 genes, of which 19 down-
regulated; Fig. S1), ribosomal pathway (19 genes, of which 18 up-
regulated; Fig. S2), long-term potentiation (LTP; 18 genes, of which
14 down-regulated; Fig. 4), and vascular endothelial growth factor
(VEGF) signalling pathway (13 genes, of which 9 down-regulated;
Fig. S3). The gene ontology classification shows corresponding gene
changes grouped by their molecular function (Table 2). Among the
statistically differentially expressed genes, changes were also found in
the expression of genes involved in the pathways related to neuronal
damage, Ca
2+ regulation, gliosis, inflammation, synaptic transmis-
sion, and cytoskeletal structure (Tables 3 and 4). These changes were
analyzed in more detail (as follows).
Gene changes related to neuronal damage and calcium-
binding proteins. Only a few genes involved in the apoptotic
pathway were changed, i.e. BAD (+1.1 fold), Bcl2-antagonist/
killer 1 (+3.31) (involved in cytochrome c release from the
mitochondria), calcineurin B (21.94), and specific components of
the cytochrome c oxidase complex (see Tables 1 and 3; and Fig.
S1). The most significantly influenced pathway was that for the
oxidative phosphorylation (Fig. S1) implicating that the primary
responses to the excitoxic damage after KA-induced SE involves
oxidative mechanisms.
The expression of calmodulin 1 (CaM1) and calmodulin 2
(CaM2) were down-regulated (21.28 and 21.05, respectively).
The expression of two specific CaM kinases, CaMKIIg and
CaMKIIb, was up-regulated (+1.61 and +0.66, respectively), and
only calcium/calmodulin-dependent protein kinase kinase 1, alpha
(CaMKK1) was down-regulated (21.06). Moreover, the calbindin
gene was down-regulated (25), whereas the expression of several
S100 calcium-binding proteins was increased. Among the small
neuronal proteins that bind CaM, the PEP-19 gene was the second
most up-regulated gene in our study (+13.3), whereas the growth
associated protein 43 (GAP-43) gene was down-regulated (21.89).
Gene changes associated with gliosis and inflamma-
tion. The structural astrocytic protein GFAP was the most
dramatically up-regulated gene (+13.7) after SE (Table 3). The
expression of the protease inhibitor cystatin C gene was
pronouncedly up-regulated (+3.58) together with one of its
substrates, cathepsin S (+6.47). Also the annexin A3 (Anxa3)
gene, which plays a role in the regulation of cellular growth,
showed an increased transcriptome expression (+7.84).
The immunologically-related beta-2 microglobulin (+3.75) and
HLA-DMB (+5.84) genes were highly up-regulated, as well as the
chemokine receptor CCR5 (+6.51) and the glycoprotein CD74 (+6.1)
genes. The interleukin 8 receptor (CXCR1) was highly down-
regulated (26.08),but prostaglandin synthase2 (PTGS2),alsoknown
as cyclooxygenase-2 (COX-2), was up-regulated (+2.48). This
inflammatory mediator is also associated to the VEGF signalling
pathway, and we found activation of several genes in this pathway
after SE (Table 1; Fig. S3). Apo E, another protein expressed in
astrocytes, showed an increased expression (+3.76).
Gene changes associated with synaptic transmis-
sion. The c-aminobutyric acid type A (GABAA) receptor a5
subunit gene expression was down-regulated (22.71), whereas the
expression of c2( +1.92) and b1( +0.99) subunits were up-regulated
(Table 4). We also detected a down-regulation of the gephyrin
(22.13) gene, and an up-regulation of the GABAA receptor-
associated protein(GABARAP;+1.81)gene.The gene expression of
the N-methyl-D-aspartate (NMDA) receptor subunit NR2C was
up-regulated (+3.78), while the NR2A subunit was down-regulated
(21.44) after SE. Furthermore, the a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) receptor subunit GluR2 was
down-regulated (21.7). The concerted action of AMPARs and
NMDARs in hippocampal CA1 pyramidal cells in the LTP
pathway is shown in Fig. 4. The G protein-coupled receptor CB1
showed an up-regulated expression (+3.76).
Validation of selected genes of interest by immuno-
histochemistry. The validation of the microarray results was
carried out by immunohistochemical detection of the selected
genes of interest, i.e. GFAP, apo E, CB1, PEP-19 and CXCR1.
Figs. 5A and 5B show representative GFAP immunostainings of
the CA1 region in a control and KA-treated rat, respectively.
GFAP was heavily increased in astrocytes of the KA-treated rats
(see Fig. 5B and the inset). Immunopositive apo E cells appeared in
the CA1 pyramidal cell layer of KA-treated rats (Fig. 5D)
compared to the control rats, in which no positively labelled
cells were detected (Fig. 5C). Furthermore, the enhanced apo E
immunoreactivity was also detected in the stratum oriens and
radiatum of the CA1 region. One of the pronouncedly increased
genes after SE in the transcriptome analysis was the CB1 gene,
which was specifically enhanced in the borders of the CA1
Seizures in Juvenile Rats
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Figs. 5E and F show the CB1 immunostaining in the CA1 region
of a control and KA-treated rat, respectively.
PEP-19 and CXCR1 were among the most up-regulated and
down-regulated genes, respectively. Figs. 6A and 6B show
representative PEP-19 immunostainings of the whole hippocam-
pus in a control and KA-treated rat, respectively. With higher
magnification, highly enhanced PEP-19 immunoreactivity was
observed in some CA1 neurons of KA-treated rats (Fig. 6D,
arrows), whereas in the majority of neurons the staining was weak
(Fig. 6D, arrowheads). Meanwhile, no PEP-19 immunoreactive
neurons could be detected in the CA1 pyramidal layer in control
rats (Fig. 6C). Figs. 6E and 6F show representative CXCR1
fluorescent immunostainings of the CA1 region in a control and
Figure 2. Heatmap of the samples assayed by microarrays. The figure illustrates the highest contrasts between the samples that were
clustered by similarity in the gene expression levels. The control samples were clearly distinguished as a coherent group separate from the samples of
KA-treated rats. Controls showed up-regulation of a specific set of genes (as indicated by yellow) in contrast to the samples of KA-treated rats
presenting down-regulated levels of the same genes (as indicated by blue), while a distinct set of genes were down-regulated in the control samples,
and up-regulated in the samples of KA-treated rats. The clustering of the genes (gene names omitted) is shown in the left vertical panel, and the
clustering of the samples is indicated in the top horizontal panel of the figure. Abbreviations: CTRL, control rat; KA, kainic acid-treated rat.
doi:10.1371/journal.pone.0010733.g002
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clusters as plotted by the log of the gene expression level of all the genes analyzed by the microrarrays. Our interest was to reveal the major
differences between the KA-treated and control rats. In the figure the samples of the control and KA-treated rats are indicted by the numbers 1–4 and
5–8, respectively, in the x-axis. Abbreviation: KA, kainic acid.
doi:10.1371/journal.pone.0010733.g003
Table 1. KEGG-test for over-representation of the pathways in response to KA-treatment.
Entry number Term or pathway P Value Odds Ratio Count Up-regulated Down-regulated
rno00190 Oxidative phosphorylation ,0.01 3.99 26 7 19
rno03050 Proteasome ,0.01 7.36 12 6 6
rno04070 Phosphatidylinositol signaling system ,0.01 3.26 16 3 13
rno03010 Ribosome ,0.01 3.07 19 18 1
rno04720 Long-term potentiation ,0.01 2.99 18 4 14
rno00100 Biosynthesis of steroids ,0.01 5.31 8 3 5
rno00562 Inositol phosphate metabolism ,0.01 3.49 11 4 7
rno05010 Alzheimer’s disease 0.01 4.21 9 5 4
rno03060 Protein export 0.01 8.77 4 0 4
rno04370 VEGF signaling pathway 0.02 2.22 13 4 9
rno04540 Gap junction 0.02 2.01 18 7 11
rno04912 GnRH signaling pathway 0.02 1.94 17 7 10
rno04730 Long-term depression 0.03 1.98 14 2 12
rno00260 Glycine, serine and threonine metabolism 0.03 2.71 8 4 4
rno00910 Nitrogen metabolism 0.05 3.75 4 0 4
doi:10.1371/journal.pone.0010733.t001
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was detected in discrete CA1 neurons of control rats (6E, arrows
and insert 1), as well as in vascular endothelial cells as identified by
their location and shape (arrowheads and insert 2). In KA-treated
rats, no clearly CXCR1 immunoreactive neurons were observed
in the CA1 layer (Fig. 6F). The immunostaining results are in line
with our corresponding gene expression findings as verified by the
microarrays.
Discussion
In this study we elucidated the consequences of KA-induced SE
on gene expression in the CA1 pyramidal cell region at the sub-
acute phase of epileptogenesis, i.e. one week after SE, in P21 rats,
the age roughly comparable to a juvenile child (reviewed in [27]).
The CA1 region was microdissected by laser, which gave us an
opportunity to focus specifically on this region selectively damaged
Figure 4. The KEGG-derived long-term potentiation pathway. The concerted action of glutamate on NMDA and AMPA receptors in CA1
pyramidal neurons is illustrated in this pathway, as well as the activation of different subpathways. The genes activated on the microarray are
encircled. The table below shows the entire list of up- or down-regulated genes related to LTP on the microarray. Abbreviations: AMPA, a-amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid; NMDA, N-methyl-D-aspartate.
doi:10.1371/journal.pone.0010733.g004
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epileptogenic process begins, and which molecular changes are
relevant to it. Earlier results, however, suggest that neurodegen-
eration, that occurs in the hilus and CA1 pyramidal cell layer
during the early phase of epileptogenesis, could be one reliable
indicator of the epileptogenic process at least in adult rats
(reviewed in [28]). A total of 1592 genes were differently expressed
in the CA1 sub-region of the KA-treated compared to their age-
matched control rats. These genes were involved in several
pathways regulating e.g. neuronal damage, Ca
2+ homeostasis, glial
reactivity, inflammation, and synaptic transmission. The observed
alterations in gene expression of the pathways of interest are
discussed in the light of earlier studies in adult rats, and their
postulated significance in epileptogenesis in juvenile rats.
Differential expression of genes related to neuronal
damage and neuroprotection
The mechanism of SE-induced CA1 pyramidal cell
damage and the role of calcium. In our model, the CA1
neurons were selectively damaged in the P21 rats one week after
SE. However, our results suggest that the activation of the
apoptotic pathway may not be involved in the damage process. In
adult rats both apoptotic and necrotic mechanisms contribute to
neuronal degeneration in all hippocampal subregions after KA-
induced SE [29,30], followed by progressive neuronal loss,
detectable within one week after SE [5,31,32]. SE-induced up-
regulation of genes associated with apoptosis, such as caspase-3,
p53, and BAX, have also been detected in adult rats [13,33,34,35].
At variance in the P21 rats, the expression of these genes did not
significantly differ from those of the control rats, although the
positive FJB-staining of CA1 neurons persisted at least for one
week. The contribution of non-apoptotic mechanisms in the CA1
region after SE is also corroborated by our recent finding that the
expression of Bax and caspase-3 proteins remained unchanged
after SE in P21 rats [23].
The S100 proteins are a family of calcium-binding, EF-hand
proteins localized to astrocytes. They are involved in Ca
2+
regulation in a variety of intracellular pathways [36]. The up-
regulation of the S100B protein has been found in previous studies
[37,38] suggesting an activation of pathways, which lead to
increased intracellular Ca
2+ concentrations in astrocytes [36]. The
calbindin gene, abundantly expressed in dentate gyrus (DG)
granule cells, and to some extent also in CA1 pyramidal neurons
[22,39], was now down-regulated. This is in accordance with
earlier studies in adult rats, in which the calbindin gene has been
down-regulated in the hippocampal subregions 1–4 weeks after
pilocarpine-induced SE [40,41], and its immunoreactivity atten-
uated in CA1 pyramidal neurons one week after KA- or
electrically-induced SE [42,43], suggesting for an attenuated
regulation of intracellular Ca
2+ levels upon stimulation [39,41].
Another highly up-regulated transcript in our study was that of
Table 2. Classification of the gene ontology by the molecular
function as revealed by the microarray study in juvenile rats
after SE.
Entry number Term
Number of
altered genes
MF00042 Nucleic acid binding 406
MF00213 Non-receptor serine/threonine
protein kinase
213
MF00262 Non-motor actin binding protein 126
MF00075 Ribosomal protein 94
MF00101 Guanyl-nucleotide exchange factor 92
MF00250 Serine protease inhibitor 81
MF00123 Oxidoreductase 67
MF00141 Hydrolase 65
MF00072 Translation initiation factor 65
MF00082 Transporter 57
MF00107 Kinase 56
MF00267 Membrane traffic protein 52
MF00137 Glycosyltransferase 47
MF00264 Microtubule family cytoskeletal
protein
45
MF00097 G-protein 45
MF00211 Kinase activator 43
MF00170 Ligase 37
MF00108 Protein kinase 37
MF00283 Ubiquitin-protein ligase 36
MF00113 Phosphatase 35
MF00021 Neuropeptide 34
MF00255 Non-motor microtubule binding
protein
34
MF00126 Dehydrogenase 33
MF00051 Helicase 27
MF00239 Phosphatase inhibitor 25
MF00094 Kinase modulator 25
MF00243 DNA helicase 25
MF00077 Chaperone 23
MF00270 Membrane traffic regulatory
protein
22
MF00268 Vesicle coat protein 22
MF00236 Exoribonuclease 20
MF00218 Calmodulin related protein 19
MF00269 SNARE protein 14
MF00139 Acyltransferase 13
MF00121 Aminoacyl-tRNA synthetase 13
MF00110 Nucleotide kinase 13
MF00119 Synthase 12
MF00147 Deaminase 11
MF00116 Nucleotide phosphatase 11
MF00150 Glycosidase 11
MF00263 Other actin family cytoskeletal
protein
9
MF00088 Apolipoprotein 9
MF00161 Decarboxylase 8
MF00155 Phosphorylase 5
Entry number Term
Number of
altered genes
MF00199 Storage protein 5
MF00200 Myelin protein 5
MF00115 Carbohydrate phosphatase 4
MF00007 Interferon receptor 3
doi:10.1371/journal.pone.0010733.t002
Table 2. Cont.
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to CaM [44]. PEP-19 is highly expressed in hippocampal CA2
pyramidal cells, which display resistance to epileptic damage
possibly due to their higher Ca
2+ buffering capacity [45].
Furthermore, PEP-19 has shown neuroprotective properties in
cell cultures, these possibly being mediated through CaM
inhibition that could lead to enhanced resistance of neurons to
calcium-mediated toxicity [46,47], which makes it tempting to
speculate that this protein is neuroprotective also in our SE model.
The reduced CaM expression in our study is also interesting since
there is extensive evidence that CaM plays a critical role in the
induction of cell death following Ca
2+ overload, and inhibition of
CaM function can protect neurons from death [48,49]. Overall,
our present results suggest that genes in the pathways regulating
the cellular Ca
2+ homeostasis are one of the major targets modified
by SE in juvenile rats. Also recent studies in adult rats suggest that
those neurons that survive after seizures exhibit prolonged
alterations in neuronal Ca
2+ dynamics that could play an
important role in the induction and maintenance of prolonged
plastic changes characteristic for the epileptic phenotype [41,50].
Genes associated with gliosis and inflammation
The structural astrocytic protein GFAP was the most dramat-
ically up-regulated gene after SE in keeping with earlier studies in
adult experimental epilepsy models, i.e. one day after KA-induced
SE [14], 14 days after pilocarpine-induced SE [21], and 8 days
after electrically-induced SE [51]. In line with the gene expression
results, enhanced GFAP protein expression has been detected
within days after SE in the hippocampus of various experimental
epilepsy models in the immature (P15–P21) [7,52], and adult rats
Table 3. Differential expression of genes in the CA1 region of KA-treated rats compared to control rats: genes associated with
neuronal damage, calcium-binding, gliosis and inflammation.
Gene databank
accession no. Gene name Gene symbol Fold change
Genes associated with neuronal damage
NM_053812 Bcl2-antagonist killer 1 Bak1 +3.31
NM_022698 Bcl2-associated death promoter Bad +1.10
NM_053586 Cytochrome c oxidase subunit 5b Cox5b +1.03
NM_182819 Cytochrome c oxidase subunit 7b Cox7b 21.07
NM_145783 Cytochrome c oxidase subunit 5a Cox5a 21.12
NM_017309 Protein phosphatase 3, regulatory subunit B, alpha isoform (calcineurin B, type I) Ppp3r1 21.94
Genes associated with calcium-binding
NM_013002 Purkinje cell protein 4 Pcp4 +13.3
XM_215607 S100 calcium binding protein A13 S100a13 +7.20
XM_579178 S100 calcium binding protein A1 S100a1 +5.10
XM_342291 S100 calcium binding protein A16 S100a16 +4.49
NM_013191 S100 calcium binding protein B S100b +3.34
NM_133605 Calcium/calmodulin-dependent protein kinase II gamma Camk2g +1.61
NM_021739 Calcium/calmodulin-dependent protein kinase II beta Camk2b +0.66
NM_017326 Calmodulin 2 Calm2 21.05
NM_031662 Calcium/calmodulin-dependent protein kinase kinase 1, alpha Camkk1 21.06
XM_579543 Calmodulin 1 Calm1 21.28
NM_017195 Growth associated protein 43 Gap43 21.89
NM_031984 Calbindin 1 Calb1 24.99
Genes associated with gliosis and inflammation
XM_579387 Glial fibrillary acid protein Gfap +13.7
NM_012823 Annexin A3 Anxa3 +7.84
NM_053960 Chemokine (C-C motif) receptor 5 Ccr5 +6.51
NM_017320 Cathepsin S Ctss +6.47
NM_013069 CD74 antigen (invariant polypeptide of major histocompatibility
complex, class II antigen-associated)
Cd74 +6.10
NM_198740 Major histocompatibility complex, class II, DM beta Hla-dmb +5.84
NM_138828 Apolipoprotein E Apoe +3.76
NM_012512 Beta-2 microglobulin B2m +3.75
NM_012837 Cystatin C Cst3 +3.58
NM_017232 Prostaglandin-endoperoxide synthase 2 Ptgs2 +2.48
NM_031560 Cathepsin K Ctsk 23.21
NM_019310 Interleukin 8 receptor, alpha Il8ra 26.08
doi:10.1371/journal.pone.0010733.t003
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fibrous astrocytes with long processes being replaced by reactive
astrocytes with thickened, heavily GFAP-postitive processes [7,37].
Comparable changes were also detected in our study corroborat-
ing the significant role of glial cells at the early phase of
epileptogenesis. The increased GFAP expression is consistent with
earlier studies of glial cell activation known to accompany different
types of neural injury [55,56].
The expression of the protease inhibitor cystatin C gene was
likewise pronouncedly up-regulated in keeping with earlier studies,
in which it has been up-regulated in reactive astrocytes, activated
microglia, and in CA1 pyramidal neurons after electrically-
induced SE in adult rats [43,51]. Functionally, cystatin C may
protect cells as it inhibits the proteolytic effect of cathepsins
[57,58]. Interestingly, also the gene expression of the lysosomal
cysteine protease cathepsin S has been up-regulated in the
Table 4. Differential expression of genes in the CA1 region of KA-treated rats compared to control rats: genes associated with
synaptic transmission, voltage-gated channels, ribosomes and cytoskeleton.
Gene databank
accession no. Gene name Gene symbol Fold change
Genes associated with synaptic transmission
NM_012575 Glutamate receptor, ionotropic, NMDA 2C Grin2c +3.78
NM_012784 Cannabinoid receptor 1 Cnr1 +3.76
NM_031853 Diazepam binding inhibitor Dbi +2.37
NM_183327 GABA-A receptor, subunit gamma 2 Gabrg2 +1.92
NM_172036 GABA-A receptor associated protein Gabarap +1.81
NM_012956 GABA-A receptor, subunit beta 1 Gabrb1 +0.99
NM_153308 Glutamate receptor, ionotropic, NMDA-associated protein 1 (glutamate binding) Grina +0.87
XM_579337 Glutamate receptor, ionotropic, NMDA 2A Grin2a 21.44
NM_017261 Glutamate receptor, ionotropic, AMPA 2 Gria2 21.7
XM_579467 Gephyrin Gphn 22.13
NM_017295 GABA-A receptor, subunit alpha 5 Gabra5 22.71
Genes associated with voltage-gated channels
NM_021688 Potassium channel, subfamily K, member 1 Kcnk1 +3.51
NM_172042 Potassium channel, subfamily K, member 2 Kcnk2 +3.32
NM_012856 Potassium voltage gated channel, Shaw-related subfamily, member 1 Kcnc1 +1.66
NM_139216 Potassium voltage gated channel, Shaw-related subfamily, member 2 Kcnc2 +1.62
NM_053351 Calcium channel, voltage-dependent, gamma subunit 2 Cacng2 +1.19
NM_139097 Sodium channel, voltage-gated, type III, beta Scn3b 21.14
NM_013186 Potassium voltage gated channel, Shab-related subfamily, member 1 Kcnb1 21.51
NM_012647 Sodium channel, voltage-gated, type 2, alpha 1 polypeptide Scn2a1 21.58
NM_024139 Calcium binding protein p22 Chp 21.64
XM_217464 Calcium binding protein 39 Cab39 21.91
Genes associated with ribosomes and cytoskeleton
NM_017138 Laminin receptor 1 (protein SA) Rpsa +3.75
NM_022504 Ribosomal protein L36 Rpl36 +3.30
NM_053597 Ribosomal protein S27 Rps27 +2.75
NM_031110 Ribosomal protein S11 Rps11 +2.39
NM_031102 Ribosomal protein L18 Rpl18 +1.95
NM_017150 Ribosomal protein L29 Rpl29 +1.93
NM_022949 Ribosomal protein L14 Rpl14 +1.61
NM_013226 Ribosomal protein L32 Rpl32 +1.41
NM_031065 Ribosomal protein L10A Rpl10a +1.34
NM_017151 Ribosomal protein S15 Rps15 +1.31
XM_575183 Ribosomal protein L21 Rpl21 +1.21
NM_031109 Ribosomal protein S10 Rps10 +1.18
NM_013066 Microtubule-associated protein 2 Mtap2 +1.12
XM_579666 Tubulin, beta 3 Tubb3 21.08
NM_031783 Neurofilament, light polypeptide Nefl 21.62
doi:10.1371/journal.pone.0010733.t004
Seizures in Juvenile Rats
PLoS ONE | www.plosone.org 10 May 2010 | Volume 5 | Issue 5 | e10733hippocampus after SE in adult rats [17], as well as in microglial
cells surrounding the degenerating CA1 pyramidal neurons in
juvenile mice [59]. Although the members of the cathepsin family
may contribute to neuronal apoptosis when secreted by activated
microglia [60,61], the significance of cathepsin S gene up-
regulation observed now remains speculative, since our other
data suggest that apoptosis seems not to be activated by SE in P21
rats.
Several genes mediating inflammatory processes were also
highly up-regulated, such as the chemokine receptor CCR5, and
the glycoprotein CD74. This is in line with earlier studies which
have shown that seizures induce the expression of different
chemokines and cytokines in adult and immature brain [7,16,52].
CCR5 is expressed in both neuronal and glial cells in the rat brain.
Moreover, its expression is time-dependently enhanced in the
adult rat hippocampus after KA-induced seizures concomitant to
neurodegeneration [62]. It has been proposed that the CCR5-
expressing glial cells could play a distinct pathophysiological role
in contributing to the progression of injury and/or be a part of
intrinsic repair mechanisms [62]. The CXCR1 gene, expressed
both in hippocampal neurons and astrocytes [63], as well as in
endothelial cells [64,65], was now down-regulated. CXCR1 is a
G-protein-coupled receptor activated by the pro-inflammatory
chemokine, interleukin-8 (IL-8 or CXCL8), that is up-regulated
under acute inflammatory conditions, e.g. after ischemia in the
adult rabbit brain [66]. IL-8 may reduce Ca
2+ currents through
CXCR1, which may modify neuronal excitability [67]. Indeed, a
neutralizing anti-IL-8 antibody has significantly reduced ischemia-
induced brain damage [66], further suggesting that inhibition of
IL-8 binding to its receptor CXCR1 is another potential target for
inhibiting the IL-8 effects [68], and the decreased CXCR1
expression may play a neuroprotective role. Moreover, activation
of the COX-2 gene occurred in our model in accordance with
earlier transcriptome studies in adult rats [13,16,69], and its
Figure 5. Validation of the microarray results by immunohistochemical staining in control and KA-treated rats. Immunoreactivity of
GFAP in a representative control (A) and KA-treated rat (B). Note the increase in GFAP immunoreactivity and the morphological change in
astrocytes of the KA-treated rat (insets in A and B). Figs 5 C and D show the immunoreactivity of apo E in a control and KA-treated rat, respectively.
Note the increase in apo E immunostaining in some cells within the CA1 pyramidal cell layer of the KA-treated rat compared to the control rat
(insets in C and D, respectively). The CB1 immunoreactivity was enhanced more pronouncedly in a KA-treated rat (F) than in a control rat (E) in the
borders of the CA1 pyramidal layer with both the stratum oriens and radiatum (white arrows in F). Scale bars: 75 mm in A–D, and 100 mm in E-F.
Abbreviations: apo E, apolipoprotein E; CB1, cannabinoid type 1 receptor; CA1 pyr, stratum pyramidale of CA1; GFAP, glial fibrillary protein; KA,
kainic acid; str., stratum.
doi:10.1371/journal.pone.0010733.g005
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hippocampal subregions, including the CA1 region after SE [23].
This inflammatory mediator is also associated to the VEGF
signalling pathway supporting the idea of recent studies that
seizures promote angiogenesis [13,70], which could contribute to
the recovery process after SE.
Apo E is postulated to modulate the astroglial response to damage,
and to play a role in neuronal repair and re-innervation of the
damaged circuitry [71]. This molecule is the major constituent of
brainlipoproteinsabundantly expressed in astrocytes [72]. It wasnow
highly up-regulated in accordance with earlier studies in the adult rat
hippocampus after systemic KA- and electrically-induced SE [51,73].
Taken together, our current transcriptome results together with the
earlier studies by other groups strongly favour the idea that activated
microglia and astrocytes play a pivotal role in immune responses as
well as in the damage and repair processes of the CA1 pyramidal
neurons in juvenile P21 rats after SE.
Genes associated with neurotransmission and signal
transduction
GABAA, NMDA and cannabinoid receptor signal-
ling. There is extensive evidence that seizures trigger
alterations in the GABAergic inhibition as well as in the GABAA
receptor subunit expression in the adult [74,75,76] and immature
(P9) rat brain [77]. Corroborating our findings, the observed
down-regulation of the a5 subunit and up-regulation of the c2
subunit along with a decreased d and increased a4 subunit
expression, have been found in several adult experimental TLE
models [16,69,74,78,79]. Interestingly, changes in these subunits
could alter both tonic and phasic inhibition, as the d, a4 and a5
subunits are primarily found in extrasynaptic GABAA receptors,
which mediate tonic inhibitory currents [80,81,82], whereas the c2
subunit is mainly localized to synaptic receptors that play a major
role in phasic inhibition [83,84]. A decreased a5 subunit
expression has, however, resulted in enhanced tonic inhibition in
Figure 6. Validation of the microarray results by immunohistochemical staining of PEP-19 and CXCR1 in control and KA-treated
rats. Immunoreactivity of PEP-19 in the whole hippocampus in a representative control (A) and KA-treated rat (B). Figs. 6C and Dshow the CA1 region
of A and B, respectively, at the higher magnification. Note the lack of PEP-19 immunoreactivity in the CA1 pyramidal layer in the control rat (C), while
the staining was weak in the CA1 layer (D, arrowheads), and greatly enhanced in single neurons (D, arrows) in the KA-treated rat. Figs. 6E and Fshow
the CXCR1 immunoreactivity in the CA1 region of a control and KA-treated rat. In control rats, immunoreactivity occurred in discrete neurons in the
CA1 pyramidal layer (E, arrows and insert 1), and in vascular endothelial cells (E, arrowheads and insert 2). In KA-treated rats, no immunoreactive
neurons could be detected (F). Scale bars: 200 mm in A–B, 40 mm in C–D, and 75 mm in E-F. Abbreviations: CXCR1, interleukin 8 receptor; PEP-19,
Purkinje cell protein 4; pyr, stratum pyramidale.
doi:10.1371/journal.pone.0010733.g006
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seizures [85] supporting the idea that compensatory up-
regulation of other extrasynaptic GABAA receptors, possibly
those containing a4 subunit, may take place. Thus, when the a5
or d subunit expression is decreased, the c2 subunit is translocated
from synaptic to perisynaptic sites and increases its partnership
with the a4 subunit in the epileptic brain [78].
We also detected a down-regulation of the gephyrin gene and
an up-regulation of the GABARAP gene in accordance with the
results obtained from the hippocampi of humans with TLE [86].
Gephyrin and GABARAP are essential proteins in the postsyn-
aptic clustering of c2 subunit-containing GABAA receptors
[87,88], and the gephyrin down-regulation could further corrob-
orate the hypothesis that the c2 subunit translocates from synaptic
to perisynaptic sites during epileptogenesis.
In hippocampal CA1 pyramidal cells, activation of NMDA
receptors and subsequent Ca
2+ influx is connected to the induction
of synaptic plasticity through LTP [89]. The low NR2A and high
NR2C transcriptome expression detected now implicates a
recapitulation of an immature NMDA receptor phenotype after
SE, as the NR2B and NR2C subunits are highly expressed in the
developing hippocampus, and around the third postnatal weeks
these two subunits are replaced by NR2A and NR2D [90].
Changes in NMDA receptor subunits have been proposed to cause
deficits in long-term spatial learning ability [91]. Furthermore, the
increased NR2C subunit expression in our model may also be
associated with the induction of CaM kinase II isoforms, which are
involved in the NMDA receptor-mediated Ca
2+ signalling in an in
vitro model of epilepsy [92].
Decreased expression of the AMPA receptor GluR2 subunit
gene has earlier been detected in the CA3 region shortly after KA-
induced and electrically-induced SE in adult rats, in keeping with
our present finding [16,93]. During the first two postnatal weeks in
rats, the expression of the GluR2 subunit-containing AMPARs are
increased in the CA1 region [90], leading to attenuated Ca
2+
influx, since this subunit exhibits low permeability to Ca
2+ [94].
The reduced expression of the GluR2 subunit in the juvenile rats
after SE could therefore lead to Ca
2+ overload in CA1 pyramidal
neurons, and contribute to their damage.
The G-protein-coupled CB1s are mainly found on the nerve
terminals of cholecystokinin-containing GABAergic interneurons
in the hippocampus [95]. Exogenous cannabinoids act on
presynaptic CB1s and block voltage-gated Ca
2+ channels and
reduce Ca
2+ influx necessary for GABA release [95,96]. This can
result in decreased GABA-mediated inhibitory currents [97] that
could facilitate LTP induction [98]. The up-regulated CB1
receptor gene expression in our study is in line with earlier
studies, in which CB1 receptors were up-regulated after seizures
in adult rats [99,100]. This suggests that the cannabinoid system
is one regulator of seizure activity. Moreover, KA-induced
seizures increase endocannabinoid levels in the normal mice
hippocampus, and induce more severe neuronal damage in the
hippocampus of CB1 knockout mice [101]. It is thus possible that
also in our juvenile rats SE-induced CB1 activation may trigger
endocannabinoid release that could serve as a neuroprotective
factor.
Concluding remarks
The transcriptome analysis of the hippocampal CA1 subregion
one week after SE in P21 rats with respect to their age-matched
control rats resulted in differentially expressed genes associated to
several pathways. Induced expression of several genes related to
the Ca
2+ signalling pathway, and the glial and inflammatory
responses were observed, but only a few genes that were related to
the apoptotic pathway. The observed absence of apoptosis may be
associated with the developmental stage of the CA1 pyramidal
neurons in P21 rats and/or a possible beneficial role of astrocytic
cells in the repair processes of pyramidal neurons. The vast
majority of the CA1 pyramidal neurons, although damaged (as
indicated by positive FJB-staining), survived at least for one week
after SE, but the altered gene expression suggest on-going
epileptogenic processes in this sub-region. The alterations in the
expression of several GABAA receptor subunits and that of CB1
may, on the other hand, be of importance for seizure regulation.
Moreover, several molecular mechanisms occurring during
epileptogenesis in our juvenile rats are similar to those in adult
rats. However, the highly up-regulated expression of the calcium-
binding protein PEP-19 gene, and the down-regulation of the
CXCR1 gene, involved in inflammation, seem to be specific for
this age. Further studies are needed to reveal whether these
molecules have a possible role in neuroprotection, and whether
they can provide new leads to better understand the mechanisms
of epileptogenesis in the juvenile hippocampus.
Supporting Information
Figure S1 The KEGG-derived oxidative phosphorylation path-
way. Oxidative phosphorylation was the most significantly
influenced pathway in our transcriptome analysis. Specific
components of the cytochrome c oxidase complex were also
activated, and these genes are encircled in the figure. The table
below shows the entire list of the up- or down-regulated genes on
the microarray related to this pathway.
Found at: doi:10.1371/journal.pone.0010733.s001 (0.99 MB TIF)
Figure S2 The KEGG-derived ribosomal pathway. The figure
shows gene changes found in the various components of the
ribosomal machinery, with the genes altered on the microarray
encircled. An increased expression of many genes encoding
ribosomal proteins was found after SE as shown in the table.
This could indicate that the cells actively change their protein
synthesis capacity after seizures.
Found at: doi:10.1371/journal.pone.0010733.s002 (0.59 MB TIF)
Figure S3 The KEGG-derived VEGF signaling pathway. The
VEGF signalling pathway with the genes activated on the
microarray encircled. In this pathway, 13 genes were changed,
of which 9 were down-regulated as seen in the table.
Found at: doi:10.1371/journal.pone.0010733.s003 (0.38 MB TIF)
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